In the acute phase of stroke, the compromised blood–brain barrier leads not only to the migration of gene-modified WBCs but is also permeable and subject to the infusion of recombinant VEGF, GDNF, and NCAM secreted by gene-modified WBCs into the bloodstream. The gene discussed is VEGFA; the disease is stroke disorder.